Mainz-Kostheim, Germany

Dirk Seiffge


Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 415(Granted Patents)


Location History:

  • Munzenberg, DE (1987 - 1991)
  • Mainz, DE (1993 - 1996)
  • Mainz-Kostheim, DE (1996 - 2005)

Company Filing History:


Years Active: 1987-2005

Loading Chart...
24 patents (USPTO):Explore Patents

Title: **Dirk Seiffge: Innovator in Leukocyte Adhesion Inhibition**

Introduction

Dirk Seiffge, based in Mainz-Kostheim, Germany, is an accomplished inventor with a significant portfolio of 24 patents. His work predominantly focuses on the development of novel compounds aimed at improving health outcomes, particularly in relation to inflammatory processes and diseases caused by excessive leukocyte adhesion.

Latest Patents

Among Dirk Seiffge's most recent innovations are two notable patents. The first patent deals with heterocytes that act as inhibitors of leukocyte adhesion and as VLA-4 antagonists. This invention details compounds that inhibit the adhesion and migration of leukocytes, which can be revolutionary in treating conditions like rheumatoid arthritis and allergic disorders by interfering with the VLA-4 receptor's interactions with its ligands. The second patent involves imidazolidine derivatives, detailing their preparation, usage, and inclusion in pharmaceutical formulations, further broadening the therapeutic possibilities in treating complex diseases.

Career Highlights

Throughout his career, Dirk has worked with prominent companies including Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His extensive experience in the pharmaceutical industry has provided him with a robust foundation to drive his innovative endeavors and contribute significantly to medical science.

Collaborations

Dirk has collaborated with esteemed colleagues such as Hans Ulrich Stilz and Volkmar Wehner, facilitating a synergistic approach to innovation that leverages shared expertise and insights in the field of pharmaceutical development.

Conclusion

In conclusion, Dirk Seiffge stands out as a significant figure in the innovative landscape of pharmaceutical science. His dedication to developing cutting-edge solutions for health challenges demonstrates the critical intersection of invention and patient care. With a robust portfolio of patents, Seiffge continues to influence the future of medical treatment and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…